KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

ACRX Predictions History

5 years ago
Allahrakha.Sheikh.107570 predicted that ACRX for 2019-04-15 is going $4.00 (17.99%)

Rank:

5 years ago
JS predicted that ACRX for 2019-04-08 is going $3.49 (2.05%)

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-04-08 is going $3.41 (-0.29%)

5 years ago
Gp predicted that ACRX for 2019-04-08 is going $3.43 (0.29%)

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-04-01 is going $3.60 (2.27%)

5 years ago
JS predicted that ACRX for 2019-04-01 is going $3.60 (3.45%)

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-03-07 is going $3.66 (-2.66%)

5 years ago
JS predicted that ACRX for 2019-03-07 is going $3.52 (-6.38%)

5 years ago
hernan predicted that ACRX for 2019-03-07 is going $3.49 (-3.32%)

Rank:

5 years ago
Bruce.Parrish.102216 predicted that ACRX for 2019-03-04 is going $3.88 (6.01%)

Rank:
Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT